|
1
|
Kawai M, Kano T, Furuhashi Y, et al:
Prognostic factors in yolk sac tumors of the ovary. A
clinicopathologic analysis of 29 cases. Cancer. 67:184–192. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dallenbach P, Bonnefoi H, Pelte MF and
Vlastos G: Yolk sac tumours of the ovary: an update. Eur J Surg
Oncol. 32:1063–1075. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kurman RJ and Norris HJ: Endodermal sinus
tumor of the ovary: a clinical and pathologic analysis of 71 cases.
Cancer. 38:2404–2419. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jimerson GK and Woodruff JD: Ovarian
extraembryonal teratoma. I. Endodermal sinus tumor. Am J Obstet
Gynecol. 127:73–79. 1977.PubMed/NCBI
|
|
5
|
Ayhan A, Taskiran C, Bozdag G, Altinbas S,
Altinbas A and Yuce K: Endodermal sinus tumor of the ovary: the
Hacettepe University experience. Eur J Obstet Gynecol Reprod Biol.
123:230–234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nawa A, Obata N, Kikkawa F, et al:
Prognostic factors of patients with yolk sac tumors of the ovary.
Am J Obstet Gynecol. 184:1182–1188. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gershenson DM, Del Junco G, Herson J and
Rutledge FN: Endodermal sinus tumor of the ovary: the M.D. Anderson
experience. Obstet Gynecol. 61:194–202. 1983.PubMed/NCBI
|
|
8
|
Mitchell PL, Al-Nasiri N, A'Hern R, et al:
Treatment of nondysgerminomatous ovarian germ cell tumors: an
analysis of 69 cases. Cancer. 85:2232–2244. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de La Motte Rouge T, Pautier P, Rey A, et
al: Prognostic factors in women treated for ovarian yolk sac
tumour: a retrospective analysis of 84 cases. Eur J Cancer.
47:175–182. 2011.PubMed/NCBI
|
|
10
|
Tong X, You Q, Li L, et al: Prognostic
factors of patients with ovarian yolk sac tumors: a study in
Chinese patients. Onkologie. 31:679–684. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sell A, Sogaard H and Norgaard-Pedersen B:
Serum alpha-fetoprotein as a marker for the effect of
post-operative radiation therapy and/or chemotherapy in eight cases
of ovarian endodermal sinus tumour. Int J Cancer. 18:574–580. 1976.
View Article : Google Scholar
|
|
12
|
Talerman A, Haije WG and Baggerman L:
Serum alpha fetoprotein (AFP) in diagnosis and management of
endodermal sinus (yolk sac) tumor and mixed germ cell tumor of the
ovary. Cancer. 41:272–278. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sessa C, Bonazzi C, Landoni F, Pecorelli
S, Sartori E and Mangioni C: Cisplatin, vinblastine, and bleomycin
combination chemotherapy in endodermal sinus tumor of the ovary.
Obstet Gynecol. 70:220–224. 1987.PubMed/NCBI
|
|
14
|
Sasaki H, Furusato M, Teshima S, et al:
Prognostic significance of histopathological subtypes in stage I
pure yolk sac tumour of the ovary. Br J Cancer. 69:529–536. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nogales FF, Bergeron C, Carvia RE, Alvaro
T and Fulwood HR: Ovarian endometrioid tumors with yolk sac tumor
component, an unusual form of ovarian neoplasm. Analysis of six
cases. Am J Surg Pathol. 20:1056–1066. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davidoff AM, Hebra A, Bunin N, Shochat SJ
and Schnaufer L: Endodermal sinus tumor in children. J Pediatr
Surg. 31:1075–1079. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen RJ, Huang SC, Chow SN, Hsieh CY, Lin
MC and Hsu HC: Influence of chemotherapy or liver metastasis on the
immunoelectrophoretic discrimination of alpha-fetoprotein from yolk
sac tumor. Int J Gynecol Cancer. 7:486–489. 1997. View Article : Google Scholar
|
|
18
|
Umezu T, Kajiyama H, Terauchi M, et al:
Long-term outcome and prognostic factors for yolk sac tumor of the
ovary. Nagoya J Med Sci. 70:29–34. 2008.PubMed/NCBI
|
|
19
|
Whiting PF, Rutjes AW, Westwood ME, et al:
QUADAS-2: a revised tool for the quality assessment of diagnostic
accuracy studies. Ann Intern Med. 155:529–536. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gershenson DM, Del Junco GD, Copeland LJ
and Rutledge FN: Mixed germ cell tumors of the ovary. Obstet
Gynecol. 64:200–206. 1984.PubMed/NCBI
|
|
22
|
Morris HH, La Vecchia C and Draper GJ:
Endodermal sinus tumor and embryonal carcinoma of the ovary in
children. Gynecol Oncol. 21:7–17. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bakri YN, Ezzat A, Akhtar, Dohami and
Zahrani: Malignant germ cell tumors of the ovary. Pregnancy
considerations. Eur J Obstet Gynecol Reprod Biol. 90:87–91. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Low JJ, Perrin LC, Crandon AJ and Hacker
NF: Conservative surgery to preserve ovarian function in patients
with malignant ovarian germ cell tumors. A review of 74 cases.
Cancer. 89:391–398. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williams S, Blessing JA, Liao SY, Ball H
and Hanjani P: Adjuvant therapy of ovarian germ cell tumors with
cisplatin, etoposide, and bleomycin: a trial of the Gynecologic
Oncology Group. J Clin Oncol. 12:701–706. 1994.PubMed/NCBI
|
|
26
|
Gershenson DM, Morris M, Cangir A, et al:
Treatment of malignant germ cell tumors of the ovary with
bleomycin, etoposide, and cisplatin. J Clin Oncol. 8:715–720.
1990.PubMed/NCBI
|
|
27
|
Cicin I, Saip P, Guney N, et al: Yolk sac
tumours of the ovary: evaluation of clinicopathological features
and prognostic factors. Eur J Obstet Gynecol Reprod Biol.
146:210–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
